BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 27184705)

  • 1. Sigma-2 receptor ligand anchored telmisartan loaded nanostructured lipid particles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in prostate cancer cells.
    Puri R; Kaur Bhatia R; Shankar Pandey R; Kumar Jain U; Katare OP; Madan J
    Drug Dev Ind Pharm; 2016 Dec; 42(12):2020-2030. PubMed ID: 27184705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.
    Sharma A; Jyoti K; Bansal V; Jain UK; Bhushan B; Madan J
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():69-76. PubMed ID: 28024639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells.
    Saini J; Bansal V; Chandra A; Madan J; Jain UK; Chandra R; Jain SM
    Colloids Surf B Biointerfaces; 2014 Jun; 118():101-10. PubMed ID: 24732397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
    Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
    J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells.
    Kaur M; Bhatia RK; Pissurlenkar RR; Coutinho EC; Jain UK; Katare OP; Chandra R; Madan J
    Carbohydr Polym; 2014 Jan; 101():614-22. PubMed ID: 24299818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin receptors targeting peptide (T7 peptide) surface-modified sorafenib nanoliposomes enhance the anti-tumor effect in colorectal cancer.
    Wang S; Sun H
    Pharm Dev Technol; 2020 Nov; 25(9):1063-1070. PubMed ID: 32589499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Delivery of Carvedilol- and Quercetin-Encapsulated Cationic Nanoliposomes for Cardiovascular Targeting: Formulation and
    Kar S; Das SS; Kundu S; Sahu BD; Kumar KJ; Kesari KK; Singh SK
    ACS Appl Bio Mater; 2024 May; 7(5):3061-3085. PubMed ID: 38581388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Cross-Linking of Nanolipoprotein Particles Substantially Enhances Serum Stability and Cellular Uptake.
    Gilmore SF; Blanchette CD; Scharadin TM; Hura GL; Rasley A; Corzett M; Pan CX; Fischer NO; Henderson PT
    ACS Appl Mater Interfaces; 2016 Aug; 8(32):20549-57. PubMed ID: 27411034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
    Li W; Huang Z; MacKay JA; Grube S; Szoka FC
    J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
    Sangwai M; Vavia P
    Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved in vitro and in vivo properties of telmisartan in the co-amorphous system with hydrochlorothiazide: A potential drug-drug interaction mechanism prediction.
    Shi X; Zhou X; Shen S; Chen Q; Song S; Gu C; Wang C
    Eur J Pharm Sci; 2021 Jun; 161():105773. PubMed ID: 33640500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate.
    Mo Y; Lim LY
    J Control Release; 2005 Sep; 107(1):30-42. PubMed ID: 16051391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
    Ranpise NS; Korabu SS; Ghodake VN
    Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coating of betanin and carvone Co-loaded nanoliposomes with synthesized cationic inulin: A strategy for enhancing the stability and bioavailability.
    Amjadi S; Almasi H; Hamishehkar H; Alizadeh Khaledabad M; Lim LT
    Food Chem; 2022 Mar; 373(Pt A):131403. PubMed ID: 34710692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanofabrications of Erythrocyte Membrane-Coated Telmisartan Delivery System Effective for Radiosensitivity of Tumor Cells in Mice Model.
    Chen S; Wang C; Meng Y; Li P; Pan Y; He M; Ni X
    Int J Nanomedicine; 2024; 19():1487-1508. PubMed ID: 38380147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
    Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
    Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telmisartan is a potent target for prevention and treatment in human prostate cancer.
    Funao K; Matsuyama M; Kawahito Y; Sano H; Chargui J; Touraine JL; Nakatani T; Yoshimura R
    Oncol Rep; 2008 Aug; 20(2):295-300. PubMed ID: 18636189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
    Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
    Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.